CVS Health (CVS) Plans Two Public Companies By 2028

• CVS Health (NYSE:CVS) plans to separate into two independent public companies by 2028, reversing its integrated healthcare structure.
• The proposed breakup would carve out the Aetna health insurance operations from CVS Health’s retail pharmacy and care delivery businesses.
• Management frames the move as a way to refocus each entity on its core operations and respond to regulatory scrutiny of vertical integration.
• The decision to split CVS Health into two listed groups sits against broader pressures our research has uncovered on the business model. Check out 1 warning sign that CVS Health investors should know about.

For readers looking beyond CVS Health and into other potential ideas in healthcare and consumer-facing services, consider exploring 27 top founder-led companies.

CVS Health runs a large US health solutions platform that links insurance benefits with retail pharmacies and care delivery. The proposed separation reshapes how one of the bigger players in healthcare is structured rather than adding a new entrant to the field.

6 things going right for CVS Health that this headline doesn't cover.

CVS Health’s split sharpens the business model, but execution risk shifts, not disappears

For the CVS Health Narrative, this breakup reinforces the core idea that the group is trying to turn healthier underwriting, pharmacy economics and tech driven savings into cleaner, more predictable operations. Separating Aetna and the health services assets from retail pharmacy ties directly into the existing focus on disciplined Aetna pricing and Caremark contract discipline, because each new company can be judged on a narrower mix of earnings drivers. The move also highlights one of the Narrative’s key watchpoints, that debt and capital allocation need careful handling, since two listed entities will each have to support their own balance sheet and cost base.

See how these catalysts shape CVS Health's path to a $116 fair value.

The practical checkpoint from here is the detailed separation blueprint CVS management has said it will deliver before the 2028 deadline, including pro forma segment margins, capital structures for each company and updated targets for Aetna underwriting, Caremark volumes and planned technology savings off the more than US$20b long term tech budget.

The CVS Health detail many holders skip sits in the boardroom, not the balance sheet

Big headlines focus on CVS Health’s structure and segments, but the quieter story is who calls the shots, how their incentives are wired, and what that means for your capital. See who is actually steering CVS Health, and how they are paid.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com